Here's a look at how some of the most active names on the market today are trading technically.

These heavily traded stocks could have some sort of a technical or fundamental catalyst driving investors' attention.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

These stocks are poised to break out and trade higher from current levels.

These stocks look poised to break out and trade higher from current levels.

TheStreet Ratings group would like to highlight 3 stocks pushing the drugs industry lower today, Feb. 25, 2013.

The Omontys recall is a crippling blow that will be hard to overcome.

A look back at why Sarepta, Arena Pharma, Galena and Affymax were among the best biopharma stocks in 2012.

The Justice Department wants to ban Sam Bankman-Fried, the former CEO of bankrupt FTX, from speaking to former employees of the crypto exchange.

The billionaire had proposed a controversial plan to end the Russia-Ukraine conflict, which now has lasted nearly a year.

The cruise line has almost fully returned to normal after the covid pandemic, but one very popular activity hasn't been brought back.